Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

See all formats and pricing


Select Volume and Issue


Evaluation of a Direct α-Amylase Assay Using 2-Chloro-4-nitrophenyl-α-D-maltotrioside

Klaus Lorentz / Barbara Gütschow / Florian Renner

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 37, Issue 11-12, Pages 1053–1062, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.1999.154, June 2005

Publication History

Published Online:


We present the adaptation of an IFCC method for α-amylase using 2-chloro-4-nitro-phenyl-α-D-maltotrioside as substrate (1) suited for routine work at 37℃. In the assay, a constant proportion of substrate, i. e. 92%, is directly converted to 2-chloro-4-nitrophenol and maltotriose. The method is based on multi- and univariate optimization leading to following measurement conditions: substrate, 2.25 mmol/l; chloride, 310 mmol/l; calcium 5.0 mmol/l; 4-morpholinoethanesulphonic acid, 50 mmol/l; pH 6.28. The assay may be carried out manually or by mechanized procedures, with substrate or sample start, and it shows these analytical properties in measuring amylase activity of sera: no lag phase, detection limit 2.9 U/l, linear range ≤820 U/l (for 300 s) or ≤1450 U/l (for 120 s of measurement), and total manual imprecision 3.2% (CV) at 46 U/l. Bilirubin ≤630 μmol/l, haemoglobin ≤6 g/l, triacylglycerols ≤30 mmol/l, heparin ≤100 kU/l, and glucose ≤120 mmol/l do not interfere. For adults, we established a preliminary 0.95-reference interval of 30–90 U/l not dependent on sex or age. A close association with the IFCC method demonstrates the reliable transfer of its measurement conditions to a robust routine method with minimal changes.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Mauro F. Larra, Thomas M. Schilling, Philipp Röhrig, and Hartmut Schächinger
Stress, 2015, Page 1
Jenalee R. Doom, Camelia E. Hostinar, Adrienne A. VanZomeren-Dohm, and Megan R. Gunnar
Psychoneuroendocrinology, 2015, Volume 59, Page 102
Veronika Engert, Franziska Plessow, Robert Miller, Clemens Kirschbaum, and Tania Singer
Psychoneuroendocrinology, 2014, Volume 45, Page 192
Biswadeep Choudhury, Shilpee Srivastava, Haider H. Choudhury, Alokananda Purkayastha, Sumita DuttaGupta, and Sankar Kumar Ghosh
Tumor Biology, 2014, Volume 35, Number 7, Page 6739
Lei Wang, Hildegard Watzlawick, Olafur Fridjonsson, Gudmundur Hreggvidsson, and Josef Altenbuchner
Biocatalysis and Biotransformation, 2013, Volume 31, Number 6, Page 335
Veronika Engert, Simona I. Efanov, Annie Duchesne, Susanne Vogel, Vincent Corbo, and Jens C. Pruessner
Psychoneuroendocrinology, 2013, Volume 38, Number 8, Page 1328
Masaki Yamaguchi, Junichi Wakasugi, and Josaku Sakakima
Clinical Biochemistry, 2008, Volume 41, Number 4-5, Page 325
Veronika Engert, Susanne Vogel, Simona I. Efanov, Annie Duchesne, Vincent Corbo, Nida Ali, and Jens C. Pruessner
Psychoneuroendocrinology, 2011, Volume 36, Number 9, Page 1294
Klaus Lorentz
Clinical Chemistry and Laboratory Medicine, 2002, Volume 40, Number 8

Comments (0)

Please log in or register to comment.